This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
